Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 320

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021: Featured Updates to the NCCN Guidelines

Pollyea, Daniel A., Bixby, Dale, Perl, Alexander, Bhatt, Vijaya Raj, Altman, Jessica K., Appelbaum, Frederick R., de Lima, Marcos, Fathi, Amir T., Foran, James M., Gojo, Ivana, Hall, Aric C., Jacoby, Meagan, Lancet, Jeffrey, Mannis, Gabriel, Marcucci, Guido, Martin, Michael G., Mims, Alice, Neff, Jadee, Nejati, Reza, Olin, Rebecca, Percival, Mary-Elizabeth, Prebet, Thomas, Przespolewski, Amanda, Rao, Dinesh, Ravandi-Kashani, Farhad, Shami, Paul J., Stone, Richard M., Strickland, Stephen A., Sweet, Kendra, Vachhani, Pankit, Wieduwilt, Matthew, Gregory, Kristina M., Ogba, Ndiya, Tallman, Martin S.·2021·Journal of the National Comprehensive Cancer Network
DOI 10.6004/jnccn.2021.0002
Open this paper in CoChat — free account

Abstract

The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment, or have yielded new information regarding factors with prognostic importance, and are intended to aid physicians with clinical decision-making. These NCCN Guidelines Insights focus on recent select updates to the NCCN Guidelines, including familial genetic alterations in AML, postinduction or postremission treatment strategies in low-risk acute promyelocytic leukemia or favorable-risk AML, principles surrounding the use of venetoclax-based therapies, and considerations for patients who prefer not to receive blood transfusions during treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2021.0002

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 320

Metadata

Authors
Pollyea, D. A., Bixby, D., Perl, A., Bhatt, V. R., Altman, J. K., Appelbaum, F. R., de Lima, M., Fathi, A. T., Foran, J. M., Gojo, I., Hall, A. C., Jacoby, M., Lancet, J., Mannis, G., Marcucci, G., Martin, M. G., Mims, A., Neff, J., Nejati, R., Olin, R., Percival, M.-E., Prebet, T., Przespolewski, A., Rao, D., Ravandi-Kashani, F., Shami, P. J., Stone, R. M., Strickland, S. A., Sweet, K., Vachhani, P., Wieduwilt, M., Gregory, K. M., Ogba, N., & Tallman, M. S.
Venue
Journal of the National Comprehensive Cancer Network
Publisher
Harborside Press, LLC
Published
2021-01-06
Volume
19
Issue
1
Pages
16-27
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
DOI
10.6004/jnccn.2021.0002
OpenAlex
W3121021979
Cited by
320
References
46
FWCI
34.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021: Featured Updates to the NCCN Guidelines. https://app.cochat.ai/papers/10.6004/jnccn.2021.0002
The paper
Pollyea, D. A., Bixby, D., Perl, A., Bhatt, V. R., Altman, J. K., Appelbaum, F. R., de Lima, M., Fathi, A. T., Foran, J. M., Gojo, I., Hall, A. C., Jacoby, M., Lancet, J., Mannis, G., Marcucci, G., Martin, M. G., Mims, A., Neff, J., Nejati, R., . . . Tallman, M. S. (2021). NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2021.0002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.